Deutsche Bank’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-94,394
Closed -$43.4K 3641
2025
Q1
$43.4K Sell
94,394
-221,265
-70% -$102K ﹤0.01% 3368
2024
Q4
$234K Buy
315,659
+249,616
+378% +$185K ﹤0.01% 2991
2024
Q3
$104K Buy
66,043
+34,153
+107% +$53.6K ﹤0.01% 3164
2024
Q2
$53.6K Sell
31,890
-6,847
-18% -$11.5K ﹤0.01% 3274
2024
Q1
$93K Sell
38,737
-1,552
-4% -$3.73K ﹤0.01% 3156
2023
Q4
$61.6K Hold
40,289
﹤0.01% 3345
2023
Q3
$43.9K Hold
40,289
﹤0.01% 3401
2023
Q2
$92.3K Sell
40,289
-12,336
-23% -$28.3K ﹤0.01% 3298
2023
Q1
$128K Buy
52,625
+15,979
+44% +$38.8K ﹤0.01% 3206
2022
Q4
$70K Buy
36,646
+556
+2% +$1.06K ﹤0.01% 3454
2022
Q3
$87K Buy
36,090
+2,998
+9% +$7.23K ﹤0.01% 3367
2022
Q2
$61K Sell
33,092
-4,803
-13% -$8.85K ﹤0.01% 3664
2022
Q1
$80K Sell
37,895
-4,516
-11% -$9.53K ﹤0.01% 3607
2021
Q4
$167K Buy
42,411
+2,158
+5% +$8.5K ﹤0.01% 3428
2021
Q3
$194K Sell
40,253
-126,028
-76% -$607K ﹤0.01% 3549
2021
Q2
$764K Buy
166,281
+78,283
+89% +$360K ﹤0.01% 2940
2021
Q1
$517K Sell
87,998
-65,178
-43% -$383K ﹤0.01% 3062
2020
Q4
$524K Sell
153,176
-466,154
-75% -$1.59M ﹤0.01% 2854
2020
Q3
$892K Buy
619,330
+599,118
+2,964% +$863K ﹤0.01% 2261
2020
Q2
$40K Buy
20,212
+6,079
+43% +$12K ﹤0.01% 3847
2020
Q1
$27K Sell
14,133
-87,323
-86% -$167K ﹤0.01% 3723
2019
Q4
$420K Sell
101,456
-25,697
-20% -$106K ﹤0.01% 2791
2019
Q3
$381K Sell
127,153
-152,042
-54% -$456K ﹤0.01% 2793
2019
Q2
$1.75M Buy
279,195
+19,028
+7% +$120K ﹤0.01% 2469
2019
Q1
$1.44M Sell
260,167
-35,452
-12% -$197K ﹤0.01% 2723
2018
Q4
$1.96M Sell
295,619
-10,923
-4% -$72.5K ﹤0.01% 2402
2018
Q3
$3.27M Sell
306,542
-25,146
-8% -$268K ﹤0.01% 2506
2018
Q2
$3.98M Sell
331,688
-95,480
-22% -$1.15M ﹤0.01% 2466
2018
Q1
$3.66M Sell
427,168
-120,951
-22% -$1.04M ﹤0.01% 2448
2017
Q4
$5.41M Buy
548,119
+217,214
+66% +$2.15M ﹤0.01% 1960
2017
Q3
$4.06M Buy
330,905
+13,259
+4% +$163K ﹤0.01% 2031
2017
Q2
$5.22M Buy
317,646
+182,554
+135% +$3M ﹤0.01% 1872
2017
Q1
$1.94M Buy
135,092
+108,516
+408% +$1.56M ﹤0.01% 2249
2016
Q4
$367K Sell
26,576
-30,597
-54% -$423K ﹤0.01% 3256
2016
Q3
$1.03M Buy
57,173
+15,147
+36% +$273K ﹤0.01% 2770
2016
Q2
$601K Buy
42,026
+2,054
+5% +$29.4K ﹤0.01% 3123
2016
Q1
$477K Buy
39,972
+24,005
+150% +$286K ﹤0.01% 3192
2015
Q4
$211K Sell
15,967
-204,145
-93% -$2.7M ﹤0.01% 3555
2015
Q3
$2.36M Buy
220,112
+192,766
+705% +$2.07M ﹤0.01% 2362
2015
Q2
$219K Sell
27,346
-56,863
-68% -$455K ﹤0.01% 3694
2015
Q1
$554K Buy
84,209
+52,378
+165% +$345K ﹤0.01% 3175
2014
Q4
$202K Buy
31,831
+29,750
+1,430% +$189K ﹤0.01% 4078
2014
Q3
$20K Sell
2,081
-35,580
-94% -$342K ﹤0.01% 4676
2014
Q2
$423K Sell
37,661
-7,698
-17% -$86.5K ﹤0.01% 3484
2014
Q1
$548K Sell
45,359
-2,236
-5% -$27K ﹤0.01% 3275
2013
Q4
$599K Sell
47,595
-77,221
-62% -$972K ﹤0.01% 2972
2013
Q3
$2.08M Buy
124,816
+12,486
+11% +$208K ﹤0.01% 2467
2013
Q2
$1.7M Buy
+112,330
New +$1.7M ﹤0.01% 2332